• SUMATRIPTAN CHEMBL128 FDA Approved

    Alternate Names:

    Sumatriptan
    Imitrex
    C1240
    Zembrace Symtouch
    Zecuity
    Youshu
    Treximet
    Teva-sumatriptan DF
    Teva-sumatriptan
    Taro-sumatriptan
    Suminat
    Sumax
    Sumavel Dosepro
    Sumatriptan Succinate
    Sumatriptan Injection, USP
    Sumatriptan Injection
    Sumatriptan DF
    Sumatran
    Sdz-sumatriptan
    Sapphirex
    Sandoz Sumatriptan
    Riva-sumatriptan
    Ratio-sumatriptan
    Q-sumatriptan
    PMS-sumatriptan
    PHL-sumatriptan
    Onzetra
    Nu-sumatriptan
    Ntp-sumatriptan DF
    Nazdav
    Mylan-sumatriptan
    Migraneitor
    Migralgin
    Imitrex Tab 100mg
    Imitrex Oral
    Imitrex Nasal Spray
    Imitrex Injection 12mg/ml
    Imitrex Inj 12mg/ml
    Imitrex Df - Tab 50mg
    Imitrex Df - Tab 25mg
    Imitrex Df - Tab 100mg
    Imitrex - Tab 50mg
    Imigrane
    Imigran mite
    Imigran Radis
    Imigran
    Imigen
    Illument
    Frimig
    Dom-sumatriptan
    Cinie
    Boots Pharmacy Migraine Relief
    Ava-sumatriptan
    Apo-sumatriptan
    Apigrane
    Altaxa
    Alsuma
    Adracon
    Act Sumatriptan
    103628-46-2
    triptan
    NP101
    3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide
    3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide
    (3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide
    DB00669
    NCGC00095838-02
    CHEBI:10650
    I06-0076
    CID5358
    3-[2-(DIMETHYLAMINO)ETHYL]-N-METHYL-1H-INDOLE-5-METHANESULFONAMIDE
    SUMATRIPTANUM
    SUMATRIPTAN (JAN/USP/INN)
    IMITREX (TN)
    GR 43175
    MLS001195659
    1H-INDOLE-5-METHANESULFONAMIDE, 3-(2-(DIMETHYLAMINO)ETHYL)-N-METHYL-
    BRD-K50938287-001-01-7
    103628-48-4 (SUCCINATE)
    IMIGRAN (TN)
    SMR000596517
    7847517
    KS-1116
    L000584
    LS-83175
    GR-43175
    SPECTRUM1505372
    UNII-8R78F6L9VO
    MLS001304742
    D00451
    1H-INDOLE-5-METHANESULFONAMIDE, 3-[2-(DIMETHYLAMINO)ETHYL]-N-METHYL-
    DAP000219
    BRN 6930870
    BIDD:GT0248
    GR 43175X
    SUMATRIPTANUM [INN-LATIN]
    C14H21N3O2S
    5358
    AC1L1K6B
    NCGC00095838-01
    AMBAP103628-46-2
    C07319
    MOLPORT-002-885-863
    BSPBIO_002304
    INCHI=1/C7H16/C1-6(2)7(3,4)5/H6H,1-5H
    I14-18984
    FT-0609092
    TR-017402
    OR246978
    OR115548
    KB-16226
    PROPYL, 1,1,2,2-TETRAMETHYL-
    AKOS015903139
    NSC-73938
    NSC 73938
    AR-1D0565
    ANW-30439
    EINECS 207-346-3
    ZINC1699401
    NSC73938
    ZISSAWUMDACLOM-UHFFFAOYSA-N
    CTK4I9357
    92340_FLUKA
    40V943JDGR
    132187_ALDRICH
    UNII-40V943JDGR
    BUTANE,2,2,3-TRIMETHYL-
    AC1Q1O1E
    ACMC-1AHI7
    2,2,3-TRIMETHYL-BUTANE
    AC1L1UDN
    BUTANE,2,3-TRIMETHYL-
    2,3-TRIMETHYLBUTANE
    PENTAMETHYLETHANE
    BUTANE, 2,2,3-TRIMETHYL-
    464-06-2
    TRIPTANE
    10044
    2,2,3-TRIMETHYLBUTANE
    OR035723
    3-[2-(DIMETHYLAMINO)ETHYL]-N-METHYL-1H-INDOLE -5-METHANESULPHONAMIDE
    (3-[2-(DIMETHYLAMINO)ETHYL]-1H-INDOL-5-YL)-N-METHYLMETHANESULFONAMIDE #
    3-[2-(DIMETHYLAMINO)ETHYL]-N-METHYL-1H-INDOLE-5-METHANESULPHONAMIDE
    3-[2-(DIMETHYLAMINO)ETHYL]-N-METHY-1H-INDOLE-5-METHANESULFONAMIDE
    3B2-0792
    AB00698285-13
    AB00698285-12
    FT-0631027
    KB-217141
    AB0016356
    SC-18016
    O262
    HE291385
    DR001144
    AJ-08373
    NCGC00095838-04
    NCGC00095838-03
    MCULE-3991948648
    AN-5271
    TOX21_111528_1
    AKOS015894924
    BDBM50005835
    TOX21_111528
    HMS3369A05
    HMS2231B21
    AVP-825
    AVP 825
    ZINC14360
    HSDB 7742
    HMDB05037
    CHEMBL3181954
    AVP825
    SUMATRIPTAN [USP:INN:BAN]
    SCHEMBL1482
    IMITREX, IMIGRAN ,TREXIMET
    GTPL54
    IMIGRAN RECOVERY
    IMIGRANREG
    CAS-103628-46-2
    DSSTOX_GSID_23628
    DSSTOX_RID_77118
    DSSTOX_CID_3628
    KQKPFRSPSRPDEB-UHFFFAOYSA-N
    8R78F6L9VO
    135651095
    54

    Drug Info:

    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications antimigraine agent
    Drug Categories vasoconstrictor agents
    Drug Categories tryptamines
    Drug Categories therapeutic uses
    Drug Categories sulfur compounds
    Drug Categories sulfones
    Drug Categories sulfonamides
    Drug Categories serotonin receptor agonists
    Drug Categories serotonin modulators
    Drug Categories serotonin agents
    Drug Categories serotonin 5-ht1 receptor agonists
    Drug Categories selective serotonin (5ht1) agonists
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories p-glycoprotein/abcb1 inhibitors
    Drug Categories organic chemicals
    Drug Categories oatp1b1/slco1b1 substrates
    Drug Categories neurotransmitter agents
    Drug Categories nervous system
    Drug Categories molecular mechanisms of pharmacological action
    Drug Categories inorganic chemicals
    Drug Categories indoles
    Drug Categories heterocyclic compounds, 2-ring
    Drug Categories heterocyclic compounds
    Drug Categories chemical actions and uses
    Drug Categories cardiovascular agents
    Drug Categories biogenic monoamines
    Drug Categories biogenic amines
    Drug Categories bcrp/abcg2 substrates
    Drug Categories antimigraine preparations
    Drug Categories analgesics
    Drug Categories amines
    Drug Categories amides
    Drug Groups investigational
    Drug Groups approved
    Drug Type small molecule
    Drug Class anti-migraine agents
    Year of Approval 1992
    (4 More Sources)